Abstract
Background As in diabetes, ulcers in leprosy occur as a result of nerve damage and loss of sensation due to neuropathy. The aim of this study is to evaluate the healing properties of raw, undiluted African honey in comparison with normal saline dressing of leprosy ulcers.
Methods This is a multi-centre, comparative, prospective, single-blinded, parallel-group, 1:1 individually randomised controlled trial to be conducted at The Leprosy Referral Hospital, Chanchaga, Niger state in central Nigeria and St. Benedict Hospital, Ogoja, Cross River state, South-south Nigeria. Raw, unadulterated honey will be used in the ulcer dressing of the eligible consenting participants in the intervention group while those in the control group will be treated by dressing with normal saline. The main outcomes will be the proportion of complete healing and the rate of healing up to 84 days post-randomisation. Follow-up will be for 6 months from randomisation. We aim to enter 90-130 participants into the study. Observations will be made by blinded observers examining photographs of ulcers.
Discussion Our study will provide an unbiased estimate of the effect of honey on the healing of neuropathic ulcers.
Trial registration ISRCTN10093277. Registered on 22 December 2021.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ISRCTN10093277
Clinical Protocols
https://trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN10093277
Funding Statement
This research was funded by the National Institute for Health and Care Research (NIHR: 200132) using UK Aid from the UK Government to support global health research. RJL is also funded by NIHR Applied Research Collaboration (ARC) West Midlands. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We received ethics approval for the study from the National Health Research Ethics Committee in Abuja (Approval Number: FHREC/2022/01/09/04-02-22)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Administrative information Note: the numbers in curly brackets in this protocol refer to SPIRIT checklist item numbers. The order of the items has been modified to group similar items (see http://www.equator-network.org/reporting-guidelines/spirit-2013-statement-defining-standard-protocol-items-for-clinical-trials/).
Funding
National Institute for Health Research (NIHR) Research and Innovation for Global Health Transformation (RIGHT). Transforming the treatment and prevention of leprosy and Buruli ulcers in LMICs. NIHR 200132.
Abbreviations
- AEs
- Adverse Events
- CI
- Chief Investigator
- GCP
- Good Clinical Practice
- HELP
- Honey Experiment on LeProsy Ulcer
- IDMC
- Independent Data Monitoring Committee
- MDT
- Multidrug Therapy
- NGDO
- Non-governmental Development Organisation
- NHREC
- National Health Research Ethics Committee
- NIHR
- National Institute for Health Research
- NIPRD
- National Institute for Pharmaceutical Research and Development
- NNN
- Neglected Tropical Disease NGDO Network
- NTD
- Neglected Tropical Disease
- PI
- Principal Investigator
- RIGHT
- Research and Innovation for Global Health Transformation
- SAEs
- Serious Adverse Events
- TLM
- The Leprosy Mission
- TLMN
- The Leprosy Mission Nigeria
- TMG
- Trial Management Group
- TSC
- Trial Steering Committee
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.